• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Innovations in Pancreatic Enzyme Replacement Therapy for Enterally Fed Patients With Pancreatic Cancer.

作者信息

Christie Whitney, Spears Claude Oather, Paul Kayla

机构信息

Whitney Christie, MS, RD, CSO, CNSC, Outpatient Oncology Dietitian, Mary Washington Healthcare & Morrison Healthcare, Fredericksburg, Virginia.

Claude Oather Spears, DNP-C, FNP-C, FAANP, BSN, BS, Medical Science Liaison, Alcresta Therapeutics.

出版信息

Gastroenterol Nurs. 2025;48(4):307-314. doi: 10.1097/SGA.0000000000000900. Epub 2025 Jul 29.

DOI:10.1097/SGA.0000000000000900
PMID:40442879
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12316150/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29df/12316150/27de80aa4c57/gastnu-48-307-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29df/12316150/84e51a4a63b6/gastnu-48-307-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29df/12316150/9d930986c721/gastnu-48-307-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29df/12316150/8fa13e65559e/gastnu-48-307-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29df/12316150/ccdaf33fcd0c/gastnu-48-307-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29df/12316150/fbd2b086384b/gastnu-48-307-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29df/12316150/d06fbd651093/gastnu-48-307-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29df/12316150/27de80aa4c57/gastnu-48-307-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29df/12316150/84e51a4a63b6/gastnu-48-307-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29df/12316150/9d930986c721/gastnu-48-307-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29df/12316150/8fa13e65559e/gastnu-48-307-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29df/12316150/ccdaf33fcd0c/gastnu-48-307-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29df/12316150/fbd2b086384b/gastnu-48-307-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29df/12316150/d06fbd651093/gastnu-48-307-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29df/12316150/27de80aa4c57/gastnu-48-307-g007.jpg

相似文献

1
Innovations in Pancreatic Enzyme Replacement Therapy for Enterally Fed Patients With Pancreatic Cancer.胰腺癌肠内营养患者胰酶替代疗法的创新
Gastroenterol Nurs. 2025;48(4):307-314. doi: 10.1097/SGA.0000000000000900. Epub 2025 Jul 29.
2
Pancreatic enzyme replacement therapy for people with cystic fibrosis.针对囊性纤维化患者的胰酶替代疗法。
Cochrane Database Syst Rev. 2016 Nov 23;11(11):CD008227. doi: 10.1002/14651858.CD008227.pub3.
3
Pancreatic enzyme replacement therapy for people with cystic fibrosis.针对囊性纤维化患者的胰酶替代疗法。
Cochrane Database Syst Rev. 2014 Oct 13(10):CD008227. doi: 10.1002/14651858.CD008227.pub2.
4
Endoscopic innovations in diagnosis and management of pancreatic cancer: a narrative review and future directions.胰腺癌诊断与治疗中的内镜创新：一篇叙述性综述及未来方向
Therap Adv Gastroenterol. 2024 Dec 10;17:17562848241297434. doi: 10.1177/17562848241297434. eCollection 2024.
5
Postoperative nutritional support after pancreaticoduodenectomy in adults.成人胰十二指肠切除术后的营养支持
Cochrane Database Syst Rev. 2025 Mar 14;3(3):CD014792. doi: 10.1002/14651858.CD014792.pub2.
6
Results of a clinical trial of ANG003, a non-porcine pancreatic enzyme replacement therapy, in people with cystic fibrosis.ANG003（一种非猪源胰酶替代疗法）用于囊性纤维化患者的临床试验结果。
J Cyst Fibros. 2025 Jul 31. doi: 10.1016/j.jcf.2025.07.008.
7
Pancreatic Enzyme Replacement Therapy in Pancreatic Exocrine Insufficiency-Real-World's Dosing and Effectiveness: A Systematic Review.胰腺外分泌功能不全的胰酶替代疗法——真实世界的剂量与疗效：一项系统评价
Dig Dis Sci. 2025 Apr 1. doi: 10.1007/s10620-025-09011-0.
8
Enzyme replacement and substrate reduction therapy for Gaucher disease.戈谢病的酶替代疗法和底物减少疗法。
Cochrane Database Syst Rev. 2015 Mar 27;2015(3):CD010324. doi: 10.1002/14651858.CD010324.pub2.
9
Pancreatic enzyme replacement therapy for enterally fed patients with cystic fibrosis.肠内喂养的囊性纤维化患者的胰腺酶替代治疗。
Nutr Clin Pract. 2013 Aug;28(4):485-9. doi: 10.1177/0884533613491786. Epub 2013 Jun 10.
10
Neoadjuvant Therapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: A Systemic Review and Meta-Analysis.可切除及边缘可切除胰腺癌的新辅助治疗与直接手术：一项系统评价和荟萃分析
J Surg Res. 2025 Jul;311:221-231. doi: 10.1016/j.jss.2025.04.042. Epub 2025 May 28.

本文引用的文献

1
Pancreatic Enzyme Replacement Therapy in Patients Undergoing First-Line Gemcitabine Plus -paclitaxel for Advanced Pancreatic Adenocarcinoma.接受一线吉西他滨联合紫杉醇治疗晚期胰腺腺癌患者的胰酶替代疗法
Front Oncol. 2021 Sep 9;11:688889. doi: 10.3389/fonc.2021.688889. eCollection 2021.
2
The use of pancreatic enzyme replacement therapy in patients with a diagnosis of chronic pancreatitis and pancreatic cancer in the US is infrequent and inconsistent.在美国，慢性胰腺炎和胰腺癌患者使用胰腺酶替代治疗的情况并不常见且不一致。
Aliment Pharmacol Ther. 2020 May;51(10):958-967. doi: 10.1111/apt.15698. Epub 2020 Apr 6.
3
Cancer statistics, 2020.
癌症统计数据，2020 年。
CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8.
4
Frequency of Appropriate Use of Pancreatic Enzyme Replacement Therapy and Symptomatic Response in Pancreatic Cancer Patients.胰腺癌患者胰腺酶替代治疗的合理应用频率和症状反应。
Pancreas. 2019 Jul;48(6):780-786. doi: 10.1097/MPA.0000000000001330.
5
The effectiveness of pancreatic enzyme replacement therapy for malabsorption in advanced pancreatic cancer, a pilot study.晚期胰腺癌吸收不良的胰酶替代疗法有效性：一项初步研究
Palliat Care. 2019 Feb 17;12:1178224218825270. doi: 10.1177/1178224218825270. eCollection 2019.
6
Enzyme replacement improves survival among patients with pancreatic cancer: Results of a population based study.酶替代疗法改善胰腺癌患者的生存：一项基于人群的研究结果。
Pancreatology. 2019 Jan;19(1):114-121. doi: 10.1016/j.pan.2018.10.010. Epub 2018 Oct 24.
7
Long-term Quality of Life and Gastrointestinal Functional Outcomes After Pancreaticoduodenectomy.胰十二指肠切除术后的长期生活质量和胃肠道功能结果。
Ann Surg. 2018 Oct;268(4):657-664. doi: 10.1097/SLA.0000000000002962.
8
Absorption and Safety With Sustained Use of RELiZORB Evaluation (ASSURE) Study in Patients With Cystic Fibrosis Receiving Enteral Feeding.接受肠内喂养的囊性纤维化患者持续使用 RELiZORB 评估（ASSURE）研究的吸收和安全性。
J Pediatr Gastroenterol Nutr. 2018 Oct;67(4):527-532. doi: 10.1097/MPG.0000000000002110.
9
Nutrition Implications for Long-Term Survivors of Pancreatic Cancer Surgery.胰腺癌手术长期幸存者的营养问题。
Nutr Clin Pract. 2017 Oct;32(5):588-598. doi: 10.1177/0884533617722929.
10
Diagnosis and treatment of pancreatic exocrine insufficiency.胰腺外分泌功能不全的诊断与治疗
Curr Opin Gastroenterol. 2018 Sep;34(5):349-354. doi: 10.1097/MOG.0000000000000459.